SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt reports Profit after tax of Rs 591.90 Mln, in the March 2023 quarter

15 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 3209.20 millions, about 19.83% up against Rs. 2678.20 millions recorded during the year-ago period.Modest increase of 15.70% in the Net Profit was reported from. 511.60 millions to Rs. 591.90  millions.Operating Profit saw a handsome growth to 846.30 millions from 711.20 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202206 202106 % Var
Sales 3209.20 2678.20 19.83 9284.40 8185.20 13.43 11144.10 10087.30 10.48
Other Income 49.70 23.50 111.49 129.30 100.90 28.15 131.90 181.00 -27.13
PBIDT 846.30 711.20 19.00 2937.90 2187.70 34.29 2808.70 2641.20 6.34
Interest 2.10 1.40 50.00 6.00 4.00 50.00 4.20 8.00 -47.50
PBDT 844.20 709.80 18.93 2931.90 2183.70 34.26 2804.50 2633.20 6.51
Depreciation 58.90 61.20 -3.76 231.20 196.10 17.90 270.80 300.40 -9.85
PBT 785.30 648.60 21.08 2700.70 1987.60 35.88 2533.70 2332.80 8.61
TAX 193.40 137.00 41.17 704.20 473.90 48.60 608.50 564.80 7.74
Deferred Tax -33.70 -5.90 471.19 -42.60 -10.90 290.83 0.40 -49.00 -100.82
PAT 591.90 511.60 15.70 1996.50 1513.70 31.90 1925.20 1768.00 8.89
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 26.37 26.56 -0.69 31.64 26.73 18.39 25.20 26.18 -3.74

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×